Table 2.
Baseline characteristics (n = 1,317)
| Clinical characteristic | Value |
|---|---|
| Age, yr | 56.6 ± 11.9 |
| Body mass index, kg/m2 | 25.3 ± 3.42 |
| Duration of hypertension, mon | 99.4 ± 88.8 |
| eGFRa, mL/min/1.73 m2 | 48.8 ± 19.4 |
| Proteinuriab | 726 (55.1) |
| Office SBP, mmHg | 137 ± 19.9 |
| 24-Hour mean SBP, mmHg | 131 ± 16.4 |
| Dipperc | 588 (44.6) |
| Male sex | 828 (62.9) |
| Causes of chronic kidney disease | |
| Hypertension | 510 (38.7) |
| Diabetes | 297 (22.6) |
| Chronic glomerulonephritis | 289 (21.9) |
| Others | 221 (16.8) |
| Current smoker | 196 (14.9) |
| Current alcohol consumer | 465 (35.3) |
| Chronic kidney disease stages | |
| 2 | 416 (31.6) |
| 3 | 640 (48.6) |
| 4 | 261 (19.8) |
| ACEi or ARB userd | 1,171 (88.9) |
Values are presented as mean ± SD or number (%).
eGFR, estimated glomerular filtration rate; SBP, systolic blood pressure; ACEi, angiotensin converting enzyme inhibitor; RB, angiotensin receptor blocker.
a
eGFR, estimated GFR calculated by MDRD.
b
Proteinuria, urine protein/creatinine ratio (mg/gCr) ≥ 300.
c
Dipper, nighttime SBP/daytime SBP ratio < 0.9.
d
Patient taking an ACEi or ARB, respectively.